These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39270452)

  • 21. Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint.
    Mardjuki R; Wang S; Carozza J; Zirak B; Subramanyam V; Abhiraman G; Lyu X; Goodarzi H; Li L
    Cell Rep; 2024 May; 43(5):114209. PubMed ID: 38749434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor.
    Guo J; Wang T; Wu T; Zhang K; Yin W; Zhu M; Pang Y; Hao C; He Z; Cheng M; Liu Y; Zheng J; Gu J; Zhao D
    Eur J Med Chem; 2020 Jan; 186():111878. PubMed ID: 31757524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structures of human ENPP1 in apo and bound forms.
    Dennis ML; Newman J; Dolezal O; Hattarki M; Surjadi RN; Nuttall SD; Pham T; Nebl T; Camerino M; Khoo PS; Monahan BJ; Peat TS
    Acta Crystallogr D Struct Biol; 2020 Sep; 76(Pt 9):889-898. PubMed ID: 32876064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one and 3,4-dihydropyrido[2,3-d]pyrimidin-2(1H)-one derivatives as novel ENPP1 inhibitors.
    Jung JE; Jang Y; Jeong HJ; Kim SJ; Park K; Oh DH; Yu A; Park CS; Han SJ
    Bioorg Med Chem Lett; 2022 Nov; 75():128947. PubMed ID: 35995398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1.
    Kato K; Nishimasu H; Oikawa D; Hirano S; Hirano H; Kasuya G; Ishitani R; Tokunaga F; Nureki O
    Nat Commun; 2018 Oct; 9(1):4424. PubMed ID: 30356045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
    Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
    Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
    J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone.
    Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
    Biochem Pharmacol; 2024 Feb; 220():116006. PubMed ID: 38142838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight into small-molecule inhibitors targeting extracellular nucleotide pyrophosphatase/phosphodiesterase1 for potential multiple human diseases.
    Du B; Ru J; Zhan Z; Lin C; Liu Y; Mao W; Zhang J
    Eur J Med Chem; 2024 Mar; 268():116286. PubMed ID: 38432057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T Cell-Derived Apoptotic Extracellular Vesicles Hydrolyze cGAMP to Alleviate Radiation Enteritis via Surface Enzyme ENPP1.
    Zhou Y; Bao L; Gong S; Dou G; Li Z; Wang Z; Yu L; Ding F; Liu H; Li X; Liu S; Yang X; Liu S
    Adv Sci (Weinh); 2024 Aug; 11(31):e2401634. PubMed ID: 38888507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance of cyclic GMP-AMP homeostasis by ENPP1 is involved in pseudorabies virus infection.
    Wang J; Lu SF; Wan B; Ming SL; Li GL; Su BQ; Liu JY; Wei YS; Yang GY; Chu BB
    Mol Immunol; 2018 Mar; 95():56-63. PubMed ID: 29407577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ENPP1's regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling.
    Carozza JA; Cordova AF; Brown JA; AlSaif Y; Böhnert V; Cao X; Mardjuki RE; Skariah G; Fernandez D; Li L
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2119189119. PubMed ID: 35588451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of 6-[(3
    Czako B; Sun Y; McAfoos T; Cross JB; Leonard PG; Burke JP; Carroll CL; Feng N; Harris AL; Jiang Y; Kang Z; Kovacs JJ; Mandal P; Meyers BA; Mseeh F; Parker CA; Yu SS; Williams CC; Wu Q; Di Francesco ME; Draetta G; Heffernan T; Marszalek JR; Kohl NE; Jones P
    J Med Chem; 2021 Oct; 64(20):15141-15169. PubMed ID: 34643390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors.
    Huang M; Huang Y; Guo J; Yu L; Chang Y; Wang X; Luo J; Huang Y; Tu Z; Lu X; Xu Y; Zhang Z; Zhang Z; Ding K
    Eur J Med Chem; 2021 Feb; 211():113023. PubMed ID: 33248853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of cGAMP-Luc, a sensitive and precise coupled enzyme assay to measure cGAMP in complex biological samples.
    Mardjuki RE; Carozza JA; Li L
    J Biol Chem; 2020 Apr; 295(15):4881-4892. PubMed ID: 32127400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
    El-Gamal MI; Ullah S; Zaraei SO; Jalil S; Zaib S; Zaher DM; Omar HA; Anbar HS; Pelletier J; Sévigny J; Iqbal J
    Eur J Med Chem; 2019 Nov; 181():111560. PubMed ID: 31382118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.
    Gupte R; Patil R; Liu J; Wang Y; Lee SC; Fujiwara Y; Fells J; Bolen AL; Emmons-Thompson K; Yates CR; Siddam A; Panupinthu N; Pham TC; Baker DL; Parrill AL; Mills GB; Tigyi G; Miller DD
    ChemMedChem; 2011 May; 6(5):922-35. PubMed ID: 21465666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-O-methyltransferase inhibitor.
    Rautio J; Leppänen J; Lehtonen M; Laine K; Koskinen M; Pystynen J; Savolainen J; Sairanen M
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2614-6. PubMed ID: 20231095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing.
    Li Z; Qin T; Li Z; Zhao X; Zhang X; Zhao T; Yang N; Miao J; Ma J; Zhang Z
    Eur J Med Chem; 2021 Dec; 225():113778. PubMed ID: 34416665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†.
    Wang W; Zhao F; Zhao Y; Pan W; Cao P; Wu L; Wang Z; Zhao X; Zhao Y; Wang H
    Anticancer Agents Med Chem; 2019; 19(2):256-264. PubMed ID: 30173652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.